Key Record Dates
ClinicalTrials.gov Identifier: | NCT04350593 |
---|---|
Brief Title: | Dapagliflozin in Respiratory Failure in Patients With COVID-19 (DARE-19) |
First Submitted : | April 14, 2020 |
First Submitted that Met QC Criteria : | April 14, 2020 |
First Posted : | April 17, 2020 |
Results First Submitted : | March 29, 2022 |
Results First Posted with QC Comments : | April 4, 2022 |
Results First Submitted that Met QC Criteria : | April 11, 2022 |
Results First Posted : | April 13, 2022 |
Last Update Submitted that Met QC Criteria : | May 13, 2022 |
Last Update Posted : | June 10, 2022 |